Hepatitis C News

Routine transgender health education is not common in U.S. medical schools. At Harvard Medical School and the University of California, San Francisco — two universities that have placed a premium on transgender health — the subject is currently covered only in elective courses. Infectious Disease News asked Katherine L. Margo, MD, associate professor of family medicine and community health in the Perelman School of Medicine at the University of Pennsylvania, if transgender health education should be required in medical school curricula.

In the last 15 years, Jae M. Sevelius, PhD, has seen positive changes in transgender health care, mainly from an awareness perspective.

Patients with chronic hepatitis C virus infection are at a higher risk of being diagnosed with around 70% of the diseases captured by the ICD-10, according to a presentation at the International Liver Congress in Paris.

PARIS — Direct-acting antiviral therapy effectively treated hepatitis C virus in patients with high MELD scores, producing a high rate of sustained viroloic response, according to a presentation at the International Liver Congress 2018.

The incidence of lymphoma — Hodgkin and non-Hodgkin — was up to 15 times higher among patents with HIV monoinfection and HIV/hepatitis C virus coinfection compared with the general population, according to findings presented at the International Liver Congress in Paris.

PARIS — In patients with hepatitis C virus genotype 4, 8 weeks of Zepatier showed effective treatment of the virus, according to a presentation at the International Liver Congress 2018.

PARIS — Although sustained virologic response maintained a high level no matter the alcohol or cannabis consumption in a German registry, those who reported drinking alcohol in excess were more likely to be lost to follow-up, according to a presentation at the International Liver Congress 2018.

PARIS — Though some direct-acting antivirals conflict with the administration of hormone replacement therapy or oral contraceptives, a recent study showed safety and efficacy with Zepatier, according to a our exclusive interview with Christophe Hezode, MD, at the International Liver Congress 2018.

PARIS — Researchers evaluated the cost-effectiveness of regular hepatocellular carcinoma screening among patients with hepatitis C after sustained virologic response. In this exclusive video from the International Liver Congress 2018, Hooman Farhang Zangneh, MD, MSc, discusses the thresholds and limitations for cost-effective liver cancer screening.

PARIS — Using a new medication and generic sofosbuvir, researchers reached 97% sustained virologic response in patients with hepatitis C both with and without cirrhosis; in this exclusive video from the International Liver Congress 2018, Drugs for Neglected Diseases Initiative (DNDi) addresses the impact of this research.